Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Лечебное дело
2020 / N 4

Поражение почек и центральной нервной системы при ВИЧ-инфекции как междисциплинарная проблема
И.Т. Муркамилов, К.А. Айтбаев, В.В. Фомин, Ж.А. Муркамилова, Ф.А. Юсупов, А.И. Счастливенко

Список литературы

1. O’Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension (Dallas, Tex.: 1979) 2005 Jul;46(1):200-4.
2. Шоломова Е.И., Ребров К.А., Оськина Н.Б. Нервная система при ВИЧ-инфицировании пациента. Бюллетень медицинских интернет-конференций 2018;8(6):252-3.
3. Фурсова Л.А., Синевич П.А. Цереброваскулярные поражения при ВИЧ-инфекции. Международный неврологический журнал 2017;3(89):136-43.
4. Fanales-Belasio E, Raimondo M, Suligoi B, Buttò S. HIV virology and pathogenetic mechanisms of infection: a brief overview. Annali dell’Istituto Superiore di Sanita 2010;46(1):5-14.
5. Maartens G, Celum C, Lewin SR. HIV infection: epidemiology, pathogenesis, treatment, and prevention. The Lancet 2014 Jul;384(9939):258-71.
6. Keyvani H, Ahmadi NA, Ranjbar MM, Kachooei SA, Ghorban K, Dadmanesh M. Immunoinformatics study of gp120 of human immunodeficiency virus type 1 subtype CRF35_AD isolated from Iranian patients. Archives of Clinical Infectious Diseases 2016;11(4):e36270.
7. Carlos MP, Anderson DE, Gardner MB, Torres JV. Immunogenicity of a vaccine preparation representing the variable regions of the HIV type 1 envelope glycoprotein. AIDS Research and Human Retroviruses 2000 Jan;16(2):153-61.
8. Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984 Dec 20-1985 Jan ;312(5996):763-7.
9. Тибекина Л.М., Малько В.А., Флуд В.В., Лепилина А.В. Церебральные инсульты у больных с ВИЧ-инфекцией. ВИЧ-инфекция и иммуносупрессии 2019;11(4):51-60.
10. Rednor SJ, Ross MJ. Molecular mechanisms of injury in HIV-associated nephropathy. Frontiers in Medicine 2018 Jun;5:177.
11. Гаджикулиева М.М., Ющук Н.Д., Мартынов Ю.В., Волгина Г.В. Частота маркеров и факторы риска повреждения почек при ВИЧ-инфекции. Здоровье населения и среда обитания 2011;6(219):33-5.
12. Galaviz KI, Gonzalez-Casanova I, Alonso A. Risk prediction in people living with human iimmunodeficiency virus: are we hitting the target? Clinical Infectious Diseases 2020 Dec;71(12):3086-7.
13. Беляков Н.А., Медведев С.В., Трофимова Т.Н. Механизмы поражения мозга при ВИЧ-инфекции. Вестник Российской академии медицинских наук 2012;67(9):4-12.
14. Barisoni L, Bruggeman LA, Mundel P, D’Agati VD, Klotman PE. HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney International 2000 Jul;58(1):173-81.
15. Mikulak J, Singhal PC. HIV-1 entry into human podocytes is mediated through lipid rafts. Kidney International 2010 Jan;77(1):72-3; author reply 73-4.
16. Мершер С., Форнони А. Патология подоцитов и нефропатия – роль сфинголипидов в гломерулярных болезнях. Нефрология 2016;20(1):10-23.
17. Li J, Das JR, Tang P, Han Z, Jaiswal JK, Ray PE. Transmembrane TNF-α facilitates HIV-1 infection of podocytes cultured from children with HIV-associated nephropathy. Journal of the American Society of Nephrology 2017 Mar;28(3):862-75.
18. Garg P. A review of podocyte biology. American Journal of Nephrology 2018;47(Suppl 1):3-13.
19. Palau L, Menez S, Rodriguez-Sanchez J, Novick T, Delsante M, McMahon BA, Atta MG. HIV-associated nephropathy: links, risks and management. HIV/AIDS (Auckland, NZ). 2018 May;10:73-81.
20. Reghine ÉL, Foresto RD, Kirsztajn GM. HIV-related nephropathy: new aspects of an old paradigm. Revista da Associação Médica Brasileira 2020 Jan;66(Suppl 1):s75-81.
21. Friedman DJ, Pollak MR. APOL1 and kidney disease: from genetics to biology. Annual Review of Physiology 2020 Feb;82:323-42.
22. Duran CE, Ramírez A, Posada JG, Schweineberg J, Mesa L, Pachajoa H, Estacio M, Manzi E, Aros V, Díaz L, Garcia VH. Prevalence of APOL1 risk variants in Afro-descendant patients with chronic kidney disease in a Latin American country. International Journal of Nephrology 2019 Dec;2019:7076326.
23. Gupta SK, Kupin W. NephMadness 2015: Infectious disease and nephrology region medscape. Available from: https://www.medscape.com/viewarticle/840389 Accessed 2020 Jan 29.
24. Матузкова А.Н., Пшеничная Н.Ю., Суладзе А.Г., Досягаева Л.И., Твердохлебова Т.И., Яговкин Э.А. Клинико-диагностическое значение оценки показателей системного воспаления у больных с ВИЧ-инфекцией. ВИЧ-инфекция и иммуносупрессии 2018;10(3):64-71.
25. Ющук Н.Д., Гаджикулиева М.М., Волгина Г.В., Захарова Е.В., Столяревич Е.С. Тромботическая микроангиопатия у пациента с ВИЧ-инфекцией (клиническое наблюдение). Инфекционные болезни: новости, мнения, обучение 2016;3(16):107-12.
26. Agrawal N, Johnston SC, Wu YW, Sidney S, Fullerton HJ. Imaging data reveal a higher pediatric stroke incidence than prior US estimates. Stroke 2009 Nov;40(11):3415-21.
27. Пономарева Е.Ю., Волошинова Е.В., Махина В.И., Голубинов Ф.Д. Тромботическая микроангиопатия, ассоциированная с ВИЧ-инфекцией. Клиническая нефрология 2019;3:42-6.
28. Bommer M, Wölfle-Guter M, Bohl S, Kuchenbauer F. The differential diagnosis and treatment of thrombotic microangiopathies. Deutsches Ärzteblatt International 2018 May;115(19):327-34.
29. Рассохин В.В., Бобровицкая Т.М. Поражения почек при ВИЧ-инфекции. Эпидемиология, подходы к классификации, основные клинические формы проявления. Часть 1. ВИЧ-инфекция и иммуносупрессии 2018;10(1):25-36.
30. Manglani M, McGavern DB. New advances in CNS immunity against viral infection. Current Opinion in Virology 2018 Feb;28:116-26.
31. Klein RS, Garber C, Funk KE, Salimi H, Soung A, Kanmogne M, Manivasagam S, Agner S, Cain M. Neuroinflammation during RNA viral infections. Annual Review of Immunology 2019 Apr;37:73-95.
32. Sumonu TA, Imarhiagbe F, Owolabi LF, Ogunrin OA, Komolafe MA, Ilesanmi OS. Cognitive functions in newly diagnosed patients with HIV infection in a tertiary health facility: assessment using community screening interview for dementia. Neurological Sciences 2017 Dec;9:8-13.
33. Davies O, Haynes BI, Casey SJ, Gerbase S, Barker GJ, Pitkanen M, Kulasegaram R, Kopelman MD. Clinical and neuroimaging correlates of cognition in HIV. Journal of Neurovirology 2019 Dec;25(6):754-64.
34. Babu H, Ambikan AT, Gabriel EE, Akusjärvi SS, Palaniapan AN, Sundaraj V, Mupanni NR, Sperk M, Cheedarla N, Sridhar R, Tripathy SP, Nowak P, Hanna LE, Neogi U. Systemic inflammation and risk of age-associated diseases in people living with HIV on long term suppressive antiretroviral therapy. bioRxiv 2019 May. Available from: https://www.biorxiv.org/content/10.1101/418012v4.full Accessed 2020 Jan 29.
35. Anand AR, Rachel G, Parthasarathy D. HIV proteins and endothelial dysfunction: implications in cardiovascular disease. Frontiers in Cardiovascular Medicine 2018 Dec;5:185.
36. Babu H, Ambikan AT, Gabriel EE, Svensson Akusjärvi S, Palaniappan AN, Sundaraj V, Mupanni NR, Sperk M, Cheedarla N, Sridhar R, Tripathy SP, Nowak P, Hanna LE, Neogi U. Systemic inflammation and the increased risk of inflamm-aging and age-associated diseases in people living with HIV on long term suppressive antiretroviral therapy. Frontiers in Immunology 2019 Aug;10:1965.
37. Zungsontiporn N, Tello RR, Zhang G, Mitchell BI, Budoff M, Kallianpur KJ, Nakamoto BK, Keating SM, Norris PJ, Ndhlovu LC, Souza SA, Shikuma CM, Chow DC. Non-classical monocytes and monocyte chemoattractant protein-1 (MCP-1) correlate with coronary artery calcium progression in chronically HIV-1 infected adults on stable antiretroviral therapy. PLoS One 2016 Feb;11(2):e0149143.
38. Шмагель К.В. Дискордантный ответ CD4+ T-лимфоцитов на антиретровирусную терапию. ВИЧ-инфекция и иммуносупрессии 2019;11(1):16-30.
39. Graham SM, Mwilu R, Liles WC. Clinical utility of biomarkers of endothelial activation and coagulation for prognosis in HIV infection: a systematic review. Virulence 2013 Aug;4(6):564-71.
40. Корсунская Л.Л., Шиян С.В. Особенности патогенеза и клинического течения цереброваскулярных заболеваний у ВИЧ-позитивных пациентов. Международный неврологический журнал 2011;4(42):66-70.
41. Minagar A, Commins D, Alexander JS, Hoque R, Chiappelli F, Singer EJ, Shapshak P. NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS. Molecular Diagnosis & Therapy 2008;12(1):25-43.
42. Levy RM, Bredesen DE, Rosenblum ML. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. Journal of Neurosurgery 1985 Apr;62(4):475-95.
43. Шилов Г.Н., Кротов А.В., Докукина Т.В. МРТ-аспекты нейровизуализации поражения ЦНС при ВИЧ-инфекции. Медицинские новости 2011;12:55-7.
44. Шишкина Е.С., Мухачева М.В., Окулова И.И. Нейрокогнитивные расстройства при ВИЧ-энцефалопатии. Вятский медицинский вестник 2018;2(58):14-7.
45. Murthy VS, Nayak AS, Joshi MK, Ninawe K. A study of neuropsychological profile of human immunodeficiency virus-positive children and adolescents on antiretroviral therapy. Indian Journal of Psychiatry 2018 Jan-Mar;60(1):114-20.
46. Carlouise J, Arulappan J, Chandrasekaran S, Ganesamurthy, Samuel A, Carlouise S, Chandy SS. Holistic humanized nursing care strategies on physiological and psychological parameters among adolescents with HIV − an interventional study. International Journal of Nutrition, Pharmacology, Neurological Diseases 2019;9(4):146-55.
47. Jayaraman K, Rangasami R, Chandrasekharan A. Magnetic resonance imaging findings in viral encephalitis: a pictorial essay. Journal of Neurosciences in Rural Practice 2018 Oct-Dec;9(4):556-60.
48. Макаров А.Ю., Чикова Р.С., Улюкин И.М., Помников В.Г. Неврологические синдромы при ВИЧ-инфекции. Неврологический журнал 2004;9(5):45-52.
49. Зайцев И.А., Мирошниченко В.А. Поражение нервной системы при ВИЧ-инфекции и СПИДе. Новости медицины и фармации 2010;330:6-14.
50. Одинак М.М., Гайкова О.Н., Литвинцев Б.С., Онищенко Л.С. Морфологические изменения головного мозга при ВИЧ-инфекции на фоне наркомании. ВИЧ-инфекция и иммуносупрессии 2013;5(1):65-75.
51. Муркамилов И.Т., Айтбаев К.А., Фомин В.В., Муркамилова Ж.А., Юсупов Ф.А., Счастливенко А.И., Райимжанов З.Р. ВИЧ-инфекция у лиц пожилого и старческого возраста: клинико-патогенетические аспекты. Терапия 2020;6(7):90-101.
52. Lin HL, Muo CH, Lin CY, Chen HJ, Chen PC. Incidence of stroke in patients with HIV infection: a population-based study in Taiwan. PLoS One 2019 May;14(5):e0217147.
53. Russo CD, Cappoli N, Coletta I, Mezzogori D, Paciello F, Pozzoli G, Battaglia A. The human microglial HMC3 cell line: where do we stand? A systematic literature review. Journal of Neuroinflammation 2018 Sep;15(1):259.
54. Шеломов А.С., Степанова Е.В., Леонова О.Н., Смирнова Н.Л. Оппортунистические заболевания как причины поражения центральной нервной системы у больных ВИЧ-инфекцией. Журнал инфектологии 2016;8(3):107-15.
55. Akase IE, Musa BO, Obiako RO, Elfulatiy A, Mohammed AA. Immune dysfunction in HIV: a possible role for pro- and anti-inflammatory cytokines in HIV staging. Journal of Immunology Research 2017;2017:4128398.
56. Kowalczyk A, Kleniewska P, Kolodziejczyk M, Skibska B, Goraca A. The role of endothelin-1 and endothelin receptor antagonists in inflammatory response and sepsis. Archivum Immunologiae et Therapiae Experimentalis 2015 Feb;63(1):41-52.
57. Jackson L, Eldahshan W, Fagan SC, Ergul A. Within the brain: the renin angiotensin system. International Journal of Molecular Sciences 2018 Mar;19(3):876.
58. Gebre AK, Altaye BM, Atey TM, Tuem KB, Berhe DF. Targeting renin-angiotensin system against Alzheimer’s disease. Frontiers in Pharmacology 2018 Apr;9:440.
59. Pausova Z, Deslauriers B, Gaudet D, Tremblay J, Kotchen TA, Larochelle P, Cowley AW, Hamet P. Role of tumor necrosis factor-alpha gene locus in obesity and obesity-associated hypertension in French Canadians. Hypertension 2000 Jul;36(1):14-9.
60. Москалец О.В. Молекулы клеточной адгезии ICAM-1 и VCAM-1 при инфекционной патологии. Тихоокеанский медицинский журнал 2018;2(72):21-5.
61. Su CM, Cheng HH, Tsai TC, Hsiao SY, Tsai NW, Chang WN, Lin WC, Cheng BC, Su YJ, Chang YT, Chiang YF, Kung CT, Lu CH. Elevated serum vascular cell adhesion molecule-1 is associated with septic encephalopathy in adult community-onset severe sepsis patients. BioMed Research International 2014;2014:598762.
62. Turner GD, Ly VC, Nguyen TH, Tran TH, Nguyen HP, Bethell D, Wyllie S, Louwrier K, Fox SB, Gatter KC, Day NP, Tran TH, White NJ, Berendt AR. Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity. The American Journal of Pathology 1998 Jun;152(6):1477-87.
63. Gao JJ, Hu YW, Wang YC, Sha YH, Ma X, Li SF, Zhao JY, Lu JB, Huang C, Zhao JJ, Zheng L, Wang Q. ApoM suppresses TNF-α-induced expression of ICAM-1 and VCAM-1 through inhibiting the activity of NF-κB. DNA and Cell Biology 2015 Aug;34(8):550-6.
64. Hsue PY, Hunt PW, Sinclair E, Bredt B, Franklin A, Killian M, Hoh R, Martin JN, McCune JM, Waters DD, Deeks SG. Increased caotid intima-media thickness in HIV patients is associated with increased cytomegalovirusspecific T-cell responses. AIDS (London, England) 2006 Nov;20(18):2275-83.
65. Zangerle R, Steinhuber S, Sarcletti M, Dierich MP, Wachter H, Fuchs D, Möst J. Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals. International Archives in Allergy and Immunology 1998 Jul;116(3):228-39.
66. Sharpstone D, Neild P, Crane R, Taylor C, Hodgson C, Sherwood R, Gazzard B, Bjarnason I. Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea. Gut 1999 Jul;45(1):70-6.
67. Klatt NR, Funderburg NT, Brenchley JM. Microbial translocation, immune activation, and HIV disease. Trends in Microbiology 2013 Jan;21(1):6-13.
68. Nazli A, Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, Gray-Owen SD, Arsenault AL, Kaushic C. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PloS Pathogens 2010 Apr;6(4):e1000852.
69. Smith AJ, Schacker TW, Reilly CS, Haase AT. A role for syndecan-1 and claudin-2 in microbial translocation during HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes (1999) 2010 Nov;55(3):306-15.
70. Ho JE, Scherzer R, Hecht FM, Maka K, Selby V, Martin JN, Ganz P, Deeks SG, Hsue PY. The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease. AIDS (London, England) 2012 Jul;26(9):1115-20.
71. Van Lelyveld SF, Gras L, Kesselring A, Zhang S, De Wolf F, Wensing AM, Hoepelman AI; ATHENA national observational cohort study. Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort. AIDS (London, England) 2012 Feb;26(4):465-74.
72. Lopera MM, Lemos Y. Factores socioeconómicos y clínicos asociados con infecciones oportunistas en pacientes con HIV afiliados al sistema de salud. Biomédica 2019;39(1):186-204.

References

1. O’Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension (Dallas, Tex.: 1979) 2005 Jul;46(1):200-4.
2. Sholomova EI, Rebrov KA, Oskina NB. Nervous system in HIV-infected patients. Bulletin of Medical Internet Conferences 2018;8(6):252-3 (In Russian).
3. Fursova LA, Sinevich PA. Cerebrovascular lesions in HIV infection. International Neurological Journal 2017;3(89):136-43 (In Russian).
4. Fanales-Belasio E, Raimondo M, Suligoi B, Buttò S. HIV virology and pathogenetic mechanisms of infection: a brief overview. Annali dell’Istituto Superiore di Sanita 2010;46(1):5-14.
5. Maartens G, Celum C, Lewin SR. HIV infection: epidemiology, pathogenesis, treatment, and prevention. The Lancet 2014 Jul;384(9939):258-71.
6. Keyvani H, Ahmadi NA, Ranjbar MM, Kachooei SA, Ghorban K, Dadmanesh M. Immunoinformatics study of gp120 of human immunodeficiency virus type 1 subtype CRF35_AD isolated from Iranian patients. Archives of Clinical Infectious Diseases 2016;11(4):e36270.
7. Carlos MP, Anderson DE, Gardner MB, Torres JV. Immunogenicity of a vaccine preparation representing the variable regions of the HIV type 1 envelope glycoprotein. AIDS Research and Human Retroviruses 2000 Jan;16(2):153-61.
8. Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984 Dec 20-1985 Jan 2;312(5996):763-7.
9. Tibekina LM, Malko VA, Flud VV, Lepilina AV. Stroke in patients with HIV infection. HIV infection and Immunosuppressive Disorders 2019;11(4):51-60 (In Russian).
10. Rednor SJ, Ross MJ. Molecular mechanisms of injury in HIV-associated nephropathy. Frontiers in Medicine 2018 Jun;5:177.
11. Gadzhikuliyeva MM, Yushchuk ND, Martynov YuV, Volgina GV. Marker frequency and risk factors for kidney damage in HIV infection. Public Health and Life Environment 2011;6(219):33-5 (In Russian).
12. Galaviz KI, Gonzalez-Casanova I, Alonso A. Risk prediction in people living with human iimmunodeficiency virus: are we hitting the target? Clinical Infectious Diseases 2020 Dec;71(12):3086-7.
13. Belyakov NA, Medvedev SV, Trofimova TN. Mechanisms of cerebral damage in patients with HIV infection. Bulletin of the Russian Academy of Medical Sciences 2012;67(9):4-12 (In Russian).
14. Barisoni L, Bruggeman LA, Mundel P, D’Agati VD, Klotman PE. HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney International 2000 Jul;58(1):173-81.
15. Mikulak J, Singhal PC. HIV-1 entry into human podocytes is mediated through lipid rafts. Kidney International 2010 Jan;77(1):72-3; author reply 73-4.
16. Mersher S, Fornoni A. Podocytes pathology and nephropathy: sphingolipids in glomerular diseases. Nephrology 2016;20(1):10-23 (In Russian).
17. Li J, Das JR, Tang P, Han Z, Jaiswal JK, Ray PE. Transmembrane TNF-α facilitates HIV-1 infection of podocytes cultured from children with HIV-associated nephropathy. Journal of the American Society of Nephrology 2017 Mar;28(3):862-75.
18. Garg P. A review of podocyte biology. American Journal of Nephrology 2018;47(Suppl 1):3-13.
19. Palau L, Menez S, Rodriguez-Sanchez J, Novick T, Delsante M, McMahon BA, Atta MG. HIV-associated nephropathy: links, risks and management. HIV/AIDS (Auckland, NZ). 2018 May;10:73-81.
20. Reghine ÉL, Foresto RD, Kirsztajn GM. HIV-related nephropathy: new aspects of an old paradigm. Revista da Associação Médica Brasileira 2020 Jan;66(Suppl 1):s75-81.
21. Friedman DJ, Pollak MR. APOL1 and kidney disease: from genetics to biology. Annual Review of Physiology 2020 Feb;82:323-42.
22. Duran CE, Ramírez A, Posada JG, Schweineberg J, Mesa L, Pachajoa H, Estacio M, Manzi E, Aros V, Díaz L, Garcia VH. Prevalence of APOL1 risk variants in Afro-descendant patients with chronic kidney disease in a Latin American country. International Journal of Nephrology 2019 Dec;2019:7076326.
23. Gupta SK, Kupin W. NephMadness 2015: Infectious disease and nephrology region medscape. Available from: https://www.medscape.com/viewarticle/840389 Accessed 2020 Jan 29.
24. Matuzkova AN, Pshenichnaya NYu, Suladze AG, Dosyagayeva LI, Tverdokhlebova TI, Yagovkin EA. Clinical and diagnostic significance of assessing indicators of systemic inflammation in patients with HIV infection. HIV Infection and Immunosuppressive Disorders 2018;10(3):64-71 (In Russian).
25. Yushchuk ND, Gadzhikuliyeva MM, Volgina GV, Zakharova EV, Stolyarevich ES. Thrombotic microangiopathy in patient with HIV infection: clinical observation. Infectious Diseases: News, Opinions, Training 2016;3(16):107-12 (In Russian).
26. Agrawal N, Johnston SC, Wu YW, Sidney S, Fullerton HJ. Imaging data reveal a higher pediatric stroke incidence than prior US estimates. Stroke 2009 Nov;40(11):3415-21.
27. Ponomareva EYu, Voloshinova EV, Makhina VI, Golubinov FD. HIV-associated thrombotic microangiopathy. Clinical Nephrology 2019;3:42-6 (In Russian).
28. Bommer M, Wölfle-Guter M, Bohl S, Kuchenbauer F. The differential diagnosis and treatment of thrombotic microangiopathies. Deutsches Ärzteblatt International 2018 May;115(19):327-34.
29. Rassokhin VV, Bobrovitskaya TM. Kidney lesions in HIV patients. Epidemiology, approaches to classification, and principal clinical manifestation. Part 1. HIV Infection and Immunosuppressive Disorders 2018;10(1):25-36 (In Russian).
30. Manglani M, McGavern DB. New advances in CNS immunity against viral infection. Current Opinion in Virology 2018 Feb;28:116-26.
31. Klein RS, Garber C, Funk KE, Salimi H, Soung A, Kanmogne M, Manivasagam S, Agner S, Cain M. Neuroinflammation during RNA viral infections. Annual Review of Immunology 2019 Apr;37:73-95.
32. Sumonu TA, Imarhiagbe F, Owolabi LF, Ogunrin OA, Komolafe MA, Ilesanmi OS. Cognitive functions in newly diagnosed patients with HIV infection in a tertiary health facility: assessment using community screening interview for dementia. Neurological Sciences 2017 Dec;9:8-13.
33. Davies O, Haynes BI, Casey SJ, Gerbase S, Barker GJ, Pitkanen M, Kulasegaram R, Kopelman MD. Clinical and neuroimaging correlates of cognition in HIV. Journal of Neurovirology 2019 Dec;25(6):754-64.
34. Babu H, Ambikan AT, Gabriel EE, Akusjärvi SS, Palaniapan AN, Sundaraj V, Mupanni NR, Sperk M, Cheedarla N, Sridhar R, Tripathy SP, Nowak P, Hanna LE, Neogi U. Systemic inflammation and risk of age-associated diseases in people living with HIV on long term suppressive antiretroviral therapy. bioRxiv 2019 May. Available from: https://www.biorxiv.org/content/10.1101/418012v4.full Accessed 2020 Jan 29.
35. Anand AR, Rachel G, Parthasarathy D. HIV proteins and endothelial dysfunction: implications in cardiovascular disease. Frontiers in Cardiovascular Medicine 2018 Dec;5:185.
36. Babu H, Ambikan AT, Gabriel EE, Svensson Akusjärvi S, Palaniappan AN, Sundaraj V, Mupanni NR, Sperk M, Cheedarla N, Sridhar R, Tripathy SP, Nowak P, Hanna LE, Neogi U. Systemic inflammation and the increased risk of inflamm-aging and age-associated diseases in people living with HIV on long term suppressive antiretroviral therapy. Frontiers in Immunology 2019 Aug;10:1965.
37. Zungsontiporn N, Tello RR, Zhang G, Mitchell BI, Budoff M, Kallianpur KJ, Nakamoto BK, Keating SM, Norris PJ, Ndhlovu LC, Souza SA, Shikuma CM, Chow DC. Non-classical monocytes and monocyte chemoattractant protein-1 (MCP-1) correlate with coronary artery calcium progression in chronically HIV-1 infected adults on stable antiretroviral therapy. PLoS One 2016 Feb;11(2):e0149143.
38. Shmagel KV. Discordant response of CD4+ T-lymphocytes to antiretroviral therapy. HIV Infection and Immunosuppressive Disorders 2019;11(1):16-30 (In Russian).
39. Graham SM, Mwilu R, Liles WC. Clinical utility of biomarkers of endothelial activation and coagulation for prognosis in HIV infection: a systematic review. Virulence 2013 Aug;4(6):564-71.
40. Korsunskaya LL, Shiyan SV. Features of pathogenesis and clinical course of cerebrovascular diseases in HIV-positive patients. International Neurological Journal 2011;4(42):66-70 (In Russian).
41. Minagar A, Commins D, Alexander JS, Hoque R, Chiappelli F, Singer EJ, Shapshak P. NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS. Molecular Diagnosis & Therapy 2008;12(1):25-43.
42. Levy RM, Bredesen DE, Rosenblum ML. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. Journal of Neurosurgery 1985 Apr;62(4):475-95.
43. Shilov GN, Krotov AV, Dokukina TV. MRI-aspects of neuroimaging of central nervous system lesions in HIV infection. Meditsinskiye Novosti 2011;12:55-7 (In Russian).
44. Shishkina ES, Mukhacheva MV, Okulova II. HIV-associated neurocognitive disorders. Vyatka Medical Bulletin 2018;2(58):14-7 (In Russian).
45. Murthy VS, Nayak AS, Joshi MK, Ninawe K. A study of neuropsychological profile of human immunodeficiency virus-positive children and adolescents on antiretroviral therapy. Indian Journal of Psychiatry 2018 Jan-Mar;60(1):114-20.
46. Carlouise J, Arulappan J, Chandrasekaran S, Ganesamurthy, Samuel A, Carlouise S, Chandy SS. Holistic humanized nursing care strategies on physiological and psychological parameters among adolescents with HIV − an interventional study. International Journal of Nutrition, Pharmacology, Neurological Diseases 2019;9(4):146-55.
47. Jayaraman K, Rangasami R, Chandrasekharan A. Magnetic resonance imaging findings in viral encephalitis: a pictorial essay. Journal of Neurosciences in Rural Practice 2018 Oct-Dec;9(4):556-60.
48. Makarov AYu, Chikova RS, Ulyukin IM, Pomnikov VG. Neurological syndromes in HIV infection. Neurological Journal 2004;9(5):45-52 (In Russian).
49. Zaytsev IA, Miroshnichenko VA. Neurological complications of HIV infection and AIDS. News of Medicine and Pharmacy 2010;330:6-14 (In Russian).
50. Odinak MM, Gaykova ON, Litvintsev BS, Onishchenko LS. Brain morphological changes in HIV infection and drug abuse. HIV infection and Immunosuppressive Disorders 2013;5(1):65-75 (In Russian).
51. Murkamilov IT, Aytbayev KA, Fomin VV, Murkamilova ZhA, Yusupov FA, Schastlivenko AI, Rayimzhanov ZR. HIV infection in elderly and senile people: clinical and pathogenetic aspects. Therapy Journal 2020;6(7):90-101 (In Russian).
52. Lin HL, Muo CH, Lin CY, Chen HJ, Chen PC. Incidence of stroke in patients with HIV infection: a population-based study in Taiwan. PLoS One 2019 May;14(5):e0217147.
53. Russo CD, Cappoli N, Coletta I, Mezzogori D, Paciello F, Pozzoli G, Battaglia A. The human microglial HMC3 cell line: where do we stand? A systematic literature review. Journal of Neuroinflammation 2018 Sep;15(1):259.
54. Shelomov AS, Stepanova EV, Leonova ON, Smirnova NL. Opportunistic diseases as the cause of central nervous system damage in patients with HIV infection. Journal Infectology 2016;8(3):107-15 (In Russian).
55. Akase IE, Musa BO, Obiako RO, Elfulatiy A, Mohammed AA. Immune dysfunction in HIV: a possible role for pro- and anti-inflammatory cytokines in HIV staging. Journal of Immunology Research 2017;2017:4128398.
56. Kowalczyk A, Kleniewska P, Kolodziejczyk M, Skibska B, Goraca A. The role of endothelin-1 and endothelin receptor antagonists in inflammatory response and sepsis. Archivum Immunologiae et Therapiae Experimentalis 2015 Feb;63(1):41-52.
57. Jackson L, Eldahshan W, Fagan SC, Ergul A. Within the brain: the renin angiotensin system. International Journal of Molecular Sciences 2018 Mar;19(3):876.
58. Gebre AK, Altaye BM, Atey TM, Tuem KB, Berhe DF. Targeting renin-angiotensin system against Alzheimer’s disease. Frontiers in Pharmacology 2018 Apr;9:440.
59. Pausova Z, Deslauriers B, Gaudet D, Tremblay J, Kotchen TA, Larochelle P, Cowley AW, Hamet P. Role of tumor necrosis factor-alpha gene locus in obesity and obesity-associated hypertension in French Canadians. Hypertension 2000 Jul;36(1):14-9.
60. Moskalets OV. Cell adhesion molecules ICAM-1 and VCAM-1 in infectious pathology. Pacific Medical Journal 2018;2(72):21-5 (In Russian).
61. Su CM, Cheng HH, Tsai TC, Hsiao SY, Tsai NW, Chang WN, Lin WC, Cheng BC, Su YJ, Chang YT, Chiang YF, Kung CT, Lu CH. Elevated serum vascular cell adhesion molecule-1 is associated with septic encephalopathy in adult community-onset severe sepsis patients. BioMed Research International 2014;2014:598762.
62. Turner GD, Ly VC, Nguyen TH, Tran TH, Nguyen HP, Bethell D, Wyllie S, Louwrier K, Fox SB, Gatter KC, Day NP, Tran TH, White NJ, Berendt AR. Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity. The American Journal of Pathology 1998 Jun;152(6):1477-87.
63. Gao JJ, Hu YW, Wang YC, Sha YH, Ma X, Li SF, Zhao JY, Lu JB, Huang C, Zhao JJ, Zheng L, Wang Q. ApoM suppresses TNF-α-induced expression of ICAM-1 and VCAM-1 through inhibiting the activity of NF-κB. DNA and Cell Biology 2015 Aug;34(8):550-6.
64. Hsue PY, Hunt PW, Sinclair E, Bredt B, Franklin A, Killian M, Hoh R, Martin JN, McCune JM, Waters DD, Deeks SG. Increased caotid intima-media thickness in HIV patients is associated with increased cytomegalovirusspecific T-cell responses. AIDS (London, England) 2006 Nov;20(18):2275-83.
65. Zangerle R, Steinhuber S, Sarcletti M, Dierich MP, Wachter H, Fuchs D, Möst J. Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals. International Archives in Allergy and Immunology 1998 Jul;116(3):228-39.
66. Sharpstone D, Neild P, Crane R, Taylor C, Hodgson C, Sherwood R, Gazzard B, Bjarnason I. Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea. Gut 1999 Jul;45(1):70-6.
67. Klatt NR, Funderburg NT, Brenchley JM. Microbial translocation, immune activation, and HIV disease. Trends in Microbiology 2013 Jan;21(1):6-13.
68. Nazli A, Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, Gray-Owen SD, Arsenault AL, Kaushic C. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PloS Pathogens 2010 Apr;6(4):e1000852.
69. Smith AJ, Schacker TW, Reilly CS, Haase AT. A role for syndecan-1 and claudin-2 in microbial translocation during HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes (1999) 2010 Nov;55(3):306-15.
70. Ho JE, Scherzer R, Hecht FM, Maka K, Selby V, Martin JN, Ganz P, Deeks SG, Hsue PY. The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease. AIDS (London, England) 2012 Jul;26(9):1115-20.
71. Van Lelyveld SF, Gras L, Kesselring A, Zhang S, De Wolf F, Wensing AM, Hoepelman AI; ATHENA national observational cohort study. Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort. AIDS (London, England) 2012 Feb;26(4):465-74.
72. Lopera MM, Lemos Y. Factores socioeconómicos y clínicos asociados con infecciones oportunistas en pacientes con HIV afiliados al sistema de salud. Biomédica 2019;39(1):186-204.

  

[ Содержание выпуска N 4 | Выпуски журнала | Список журналов ]